In the evolving landscape of global healthcare, Taiwan has emerged as a premier center for the development, production, and export of Single Herb Granules. The intersection of deeply rooted Traditional Chinese Medicine (TCM) practices and Taiwan’s world-class pharmaceutical manufacturing standards creates a unique value proposition for practitioners and distributors worldwide.
At Neo-Green Herbs, we leverage this rigorous environment to supply herbal extracts that meet the highest international safety profiles. Taiwan’s regulatory framework for TCM, particularly its strict adherence to PIC/S GMP (Pharmaceutical Inspection Co-operation Scheme Good Manufacturing Practice), ensures that every granule produced offers consistent potency, purity, and safety. This is not merely about producing herbs; it is about engineering a clinical-grade product that integrates seamlessly into modern health systems.
The transition from raw bulk herbs to standardized single herb granules has been a hallmark of Taiwan's TCM advancement. This shift allows for:
The pharmaceutical industry in Taiwan has invested heavily in "Smart TCM" technology. This involves high-tech extraction facilities that utilize vacuum drying and low-temperature processing to preserve the volatile oils and active ingredients of the herbs.
In local Taiwan clinics and hospitals, these granules are part of the National Health Insurance (NHI) system, a testament to their efficacy and safety. This institutional trust allows us to export the same high-quality products to clinics in North America, Europe, and Southeast Asia. Whether it is Sichuan Lovage Rhizome for blood circulation or Chinese Yam for digestive support, our products are backed by decades of clinical usage and continuous quality verification.
Years of R&D Experience
GMP Compliance
Global Markets Served
Neo-Green Herbs
